Effect of exercise on quality of life in patients with covert hepatic encephalopathy
Not Applicable
- Conditions
- Covert hepatic encephalopathy
- Registration Number
- JPRN-UMIN000029261
- Lead Sponsor
- Hyogo college of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with severe depression or psychiatric disorder 2.Patients with severe OHE who are expected to be difficult to participate in this study. 3.Patients with severe underlying diseases or advanced malignancies. 4.Pregnant or lactating female patients 5.Patients who were judged to be inappropriate for the study subjects
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation for ADL using actigram
- Secondary Outcome Measures
Name Time Method Questionaire survey Clinical time course in baseline characteristics and brain MRI findings.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link exercise to improved neurocognitive outcomes in covert hepatic encephalopathy?
How does structured exercise compare to lactulose/rifaximin in managing minimal hepatic encephalopathy symptoms?
Which biomarkers (e.g., serum ammonia, inflammatory cytokines) predict response to exercise in CHE patients?
What adverse events are associated with exercise interventions in liver disease populations and how are they managed?
Are there synergistic effects of combining aerobic exercise with pharmacological agents for CHE treatment?